Cathelicidin LL-37: A central factor in the pathogenesis of inflammatory dermatoses? [Cathelicidin LL-37: Ein zentraler faktor in der pathogenese entzündlicher dermatosen?]

被引:0
|
作者
Schauber J. [1 ,2 ]
Ruzicka T. [1 ]
Rupec R.A. [1 ]
机构
[1] Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität München, 80337 München
来源
Der Hautarzt | 2008年 / 59卷 / 1期
关键词
Antimicrobial peptides; Atopic eczema; Cathelicidin; Psoriasis; Rosacea;
D O I
10.1007/s00105-007-1457-z
中图分类号
学科分类号
摘要
Keratinocytes produce and secrete antimicrobial peptides which function as endogenous antibiotics and as signaling molecules within the cutaneous innate immune system. Recent studies demonstrate that the antimicrobial peptide cathelicidin LL-37 plays an important role in the pathogenesis of atopic eczema, rosacea and psoriasis. Whereas skin in atopic eczema shows decreased cathelicidin expression which leads to increased susceptibility to superinfection in those patients, overabundant expression of cathelicidin peptide fragments causes inflammation in rosacea. Finally, in psoriasis cathelicidin peptide binds to self DNA which triggers an autoimmune response. These studies demonstrate the role of cathelicidin as a central factor in the pathogenesis of cutaneous inflammation. Therapies targeting cathelicidin expression and function could lead to new treatments for these diseases. © 2007 Springer Medizin Verlag.
引用
收藏
页码:72 / 74
页数:2
相关论文
共 50 条
  • [31] The role of the microenvironment protein cathelicidin LL-37 in pancreatic ductal adenocarcinoma
    Sainz, Bruno, Jr.
    Frias, Javier
    Cloffi, Michele
    Alcala, Sonia
    Heeschen, Christopher
    CANCER RESEARCH, 2013, 73
  • [32] Pulmonary defense and the human cathelicidin hCAP-18/LL-37
    Fahy, RJ
    Wewers, MA
    IMMUNOLOGIC RESEARCH, 2005, 31 (02) : 75 - 89
  • [33] The roles of cathelicidin LL-37 in immune defences and novel clinical applications
    Nijnik, Anastasia
    Hancock, Robert E. W.
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (01) : 41 - 47
  • [34] LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
    Adam Fabisiak
    Natalia Murawska
    Jakub Fichna
    Pharmacological Reports, 2016, 68 : 802 - 808
  • [35] Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
    Miao, Shuo
    Liu, Houde
    Yang, Qingyu
    Zhang, Yaping
    Chen, Tao
    Chen, Shuai
    Mao, Xin
    Zhang, Qingsong
    PHARMACOLOGICAL RESEARCH, 2024, 210
  • [36] The Human Cathelicidin LL-37, a Defensive Peptide Against Rotavirus Infection
    Zohreh Hosseini
    Mohammad Bagher Habibi Najafi
    Masoud Yavarmanesh
    Angila Ataei-Pirkooh
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 911 - 919
  • [37] In silico assessment of missense point mutations on human cathelicidin LL-37
    Porto, William F.
    Alencar, Sergio A.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2023, 118
  • [38] Expression of B-defensins, cathelicidin (LL-37) in skin tumors
    Whang, Kyu Uang
    Mo, Gang
    Lee, Jong Suk
    Lip, Young
    Lee, Jung Eun
    Hoon, Jung
    Park, Yoon Ji
    Il, Seung
    Kim, Ji Hoon
    Ki, Hong
    JOURNAL OF DERMATOLOGY, 2012, 39 : 34 - 34
  • [39] Serum levels of peptide cathelicidin LL-37 in elderly patients with depression
    Kozlowska, Elzbieta
    Wysokinski, Adam
    Brzezinska-Blaszczyk, Ewa
    PSYCHIATRY RESEARCH, 2017, 255 : 156 - 160
  • [40] Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases
    Majewski, Karol
    Zelechowska, Paulina
    Brzezinska-Blaszczyk, Ewa
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (01): : E34 - E39